Many COVID-19-related clinical trials have several methodological flaws, and...
Central Drug Standards Control Organisation
Jacob Puliyel has submitted that there is no reason...
Virafin's phase 2 trial has several methodological and reporting...
SputnikĀ V, developed by Moscow's Gamaleya Institute, has proved 91.6%...
Photo: Dan Asaki/Unsplash. Bengaluru: As the world scrambled to...
Most members of the same group had written a...
News of the reported efficacy is tempered by the...












